163 related articles for article (PubMed ID: 29858127)
1. Action Needed on Chlamydia Vaccines.
Starnbach MN
Trends Microbiol; 2018 Aug; 26(8):639-640. PubMed ID: 29858127
[TBL] [Abstract][Full Text] [Related]
2. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
Agrawal T; Vats V; Salhan S; Mittal A
J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
[TBL] [Abstract][Full Text] [Related]
3. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
4. Chlamydial protease-like activity factor--insights into immunity and vaccine development.
Murthy AK; Guentzel MN; Zhong G; Arulanandam BP
J Reprod Immunol; 2009 Dec; 83(1-2):179-84. PubMed ID: 19853923
[TBL] [Abstract][Full Text] [Related]
5. Update on Chlamydia trachomatis Vaccinology.
de la Maza LM; Zhong G; Brunham RC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
[TBL] [Abstract][Full Text] [Related]
6. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
7. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection.
Gray RT; Beagley KW; Timms P; Wilson DP
J Infect Dis; 2009 Jun; 199(11):1680-8. PubMed ID: 19432550
[TBL] [Abstract][Full Text] [Related]
8. Towards a Chlamydia vaccine. Interview by Kelly McCauley.
Igietseme J
Expert Rev Vaccines; 2004 Jun; 3(3):237-42. PubMed ID: 15176940
[No Abstract] [Full Text] [Related]
9. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis control requires a vaccine.
Brunham RC; Rappuoli R
Vaccine; 2013 Apr; 31(15):1892-7. PubMed ID: 23375977
[TBL] [Abstract][Full Text] [Related]
11. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
Poston TB; Gottlieb SL; Darville T
Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
[TBL] [Abstract][Full Text] [Related]
13. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the rational design of a Chlamydia vaccine.
Liang S; Bulir D; Kaushic C; Mahony J
Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for Chlamydia infections of the female genital tract.
Hafner LM; McNeilly C
Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
[TBL] [Abstract][Full Text] [Related]
16. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
[TBL] [Abstract][Full Text] [Related]
17. HtrA, RseP, and Tsp proteins do not elicit a pathology-related serum IgG response during sexually transmitted infection with Chlamydia trachomatis.
Huston WM; Armitage CW; Lawrence A; Gloeckl S; Bell SJ; Debattista J; Allan JA; Timms P;
J Reprod Immunol; 2010 Jun; 85(2):168-71. PubMed ID: 20444505
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
Beagley KW; Timms P
J Reprod Immunol; 2000 Aug; 48(1):47-68. PubMed ID: 10996382
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.
Chavez JM; Vicetti Miguel RD; Cherpes TL
Infect Dis Obstet Gynecol; 2011; 2011():754060. PubMed ID: 22144851
[TBL] [Abstract][Full Text] [Related]
20. 1989 Canadian guidelines for screening for Chlamydia trachomatis infection.
Can Dis Wkly Rep; 1989 Nov; 15 Suppl 5():1-13. PubMed ID: 2611925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
